ArticleClinical and experimental medicine2025

Identification of glucuronic acid as a biomarker of poor prognosis in acute myeloid leukemia based on plasma metabolomics.

Jinrong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.